Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging - EP2776066

The patent EP2776066 was granted to Universit Laval on Sep 19, 2018. The application was originally filed on Nov 6, 2012 under application number EP12847546A. The patent is currently recorded with a legal status of "Revoked".

EP2776066

UNIVERSIT LAVAL
Application Number
EP12847546A
Filing Date
Nov 6, 2012
Status
Revoked
Jan 15, 2021
Grant Date
Sep 19, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBJun 18, 2019LAHRTZ -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0404097
DESCRIPTIONUS4816567
DESCRIPTIONUS6017729
DESCRIPTIONUS6242213
DESCRIPTIONWO9311161
DESCRIPTIONWO9828426
DESCRIPTIONWO9929865
INTERNATIONAL-SEARCH-REPORTUS2003021785
INTERNATIONAL-SEARCH-REPORTWO02092016
OPPOSITIONWO02076507
OPPOSITIONWO02092016
OPPOSITIONWO2013067639
SEARCHUS2002086312
SEARCHUS2005031583

Non-Patent Literature (NPL) Citations (124) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ACHARYYA S; GUTTRIDGE DC, "Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome", Clin Cancer Res., (20070000), vol. 13, pages 1356 - 1361-
DESCRIPTION- ANDERSON et al., Nature, (19970000), vol. 390, pages 175 - 179-
DESCRIPTION- BERGH JJ; XU Y, "Farach-Carson MC. Osteoprotegerin expression and secretion are regulated by Ca2+ influx through the L-type voltage-sensitive Ca2+ channel", Endocrinology, (20040000), vol. 145, pages 426 - 436-
DESCRIPTION- BLOOMFIELD SA., "Changes in musculoskeletal structure and function with prolonged bed rest", Med Sci Sports Exerc., (19970000), vol. 29, pages 197 - 206-
DESCRIPTION- BODENSTEINER JB; ENGEL AG, "Intracellular Ca2+ accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies", Neurology, (19780000), vol. 5, pages 439 - 46-
DESCRIPTION- BOERNER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95-
DESCRIPTION- BOSS GR; SEEGMILLER JE, "Age-related physiological changes and their clinical significance", West J Med., (19810000), vol. 135, pages 434 - 440-
DESCRIPTION- BROOKS SV; FAULKNER JA, "Contractile properties of skeletal muscles from young, adult and aged mice", J Physiol., (19880000), vol. 404, pages 71 - 82-
DESCRIPTION- BRUNING JC; MICHAEL MD; WINNAY JN; HAYASHI T; HORSCH D; ACCILI D; GOODYEAR LJ; KAHN CR, "A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance", Mol Cell, (19980000), vol. 2, pages 559 - 569-
DESCRIPTION- BUCAY N; SAROSI I; DUNSTAN CR; MORONY S; TARPLEY J; CAPPARELLI C; SCULLY S; TAN HL; XU W; LACEY DL, "osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification", Genes Dev., (19980000), vol. 12, pages 1260 - 1268-
DESCRIPTION- BU YH; HE YL; ZHOU HD; LIU W; PENG D; TANG AG; TANG LL; XIE H; HUANG QX; LUO XH, "Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells", J Endocrinol, (20100000), vol. 206, pages 271 - 277-
DESCRIPTION- CAFFREY JM; FARACH-CARSON MC, "Vitamin D3 metabolites modulate dihydropyridinesensitive Ca2+ currents in clonal rat osteosarcoma cells", J Biol Chem., (19890000), vol. 264, pages 20265 - 20274-
DESCRIPTION- CHAKKALAKAL JV; HARRISON MA; CARBONETTO S; CHIN E; MICHEL RN; JASMIN BJ, "Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice", Hum Mol Genet, (20040000), vol. 13, pages 379 - 88-
DESCRIPTION- CHAN S; HEAD SI, "Age- and gender-related changes in contractile properties of nonatrophied EDL muscle", PLoS One, (20100000), vol. 5, page e12345-
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628-
DESCRIPTION- CLARKE BA; DRUJAN D; WILLIS MS; MURPHY LO; CORPINA RA; BUROVA E; RAKHILIN SV; STITT TN; PATTERSON C; LATRES E, "The E3 Ligase MuRFl degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle", Cell Metab., (20070000), vol. 6, pages 376 - 385-
DESCRIPTION- COLE et al., Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, (19850000), page 77-
DESCRIPTION- CRABTREE GR, "Ca2+, calcineurin, and the control of transcription", J Biol Chem., (20010000), vol. 276, pages 2313 - 2316-
DESCRIPTION- CUNNINGHAM LS; KELSEY JL, "Epidemiology of musculoskeletal impairments and associated disability", Am J Public Health., (19840000), vol. 74, pages 574 - 579-
DESCRIPTION- DE LETTER MA; SCHMITZ PI; VISSER LH; VERHEUL FA; SCHELLENS RL; OP DE COUL DA; VAN DER MECHE FG, "Risk factors for the development of polyneuropathy and myopathy in critically ill patients", Crit Care Med., (20010000), vol. 29, pages 2281 - 2286-
DESCRIPTION- DEVOL DL; ROTWEIN P; SADOW JL; NOVAKOFSKI J; BECHTEL PJ, "Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth", Am J Physiol., (19900000), vol. 259, pages E89 - 95, XP000676549-
DESCRIPTION- DI MONACO M; VALLERO F; DI MONACO R; TAPPERO R, "Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture", Arch Gerontol Geriatr., (20110000), vol. 52, pages 71 - 74, XP027536404-
DESCRIPTION- DORE RK; COHEN SB; LANE NE; PALMER W; SHERGY W; ZHOU L; WANG H; TSUJI W; NEWMARK R, "Denosumab RA Study Group. Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates", Ann Rheum Dis., (20100000), vol. 69, pages 872 - 875-
DESCRIPTION- DZHURA I; WU Y; COLBRAN RJ; BALSER JR; ANDERSON ME, "Calmodulin kinase determines Ca2+ -dependent facilitation of L-type Ca2+ channels", Nat Cell Biol., (20000000), vol. 2, pages 173 - 177-
DESCRIPTION- EAPEN AS; SUNDIVAKKAM P; SONG Y; RAVINDRAN S; RAMACHANDRAN A; TIRUPPATHI C; GEORGE A, "Ca2+ -mediated stress kinase activation by DMP1 promotes osteoblast differentiation", J Biol Chem., (20100000), vol. 285, pages 36339 - 36351-
DESCRIPTION- FERRAND-DRAKE M; ZHU C; GIDO G; HANSEN AJ; KARLSSON JO; BAHR BA; ZAMZAMI N; KROEMER G; CHAN PH; WIELOCH T, "Cyclosporin A prevents calpain activation despite increased intracellular Ca2+ concentrations, as well as translocation of apoptosisinducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia", J Neurochem, (20030000), vol. 85, pages 1431 - 1442-
DESCRIPTION- FERRETTI R; MARQUES MJ; PERTILLE A; SANTO NETO H, "Sarcoplasmic-endoplasmic-reticulum Ca2+-ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin-deficient mdx mice", Muscle Nerve, (20090000), vol. 39, pages 609 - 15-
DESCRIPTION- FRENETTE J; ST-PIERRE M; COTE CH; MYLONA E; PIZZA FX, "Muscle impairment occurs rapidly and precedes inflammatory cell accumulation after mechanical loading", Am J Physiol Regul Integr Comp Physiol., (20020000), vol. 282, pages R351 - 357-
DESCRIPTION- FRENETTE J; ST-PIERRE M; COTE CH; MYLONA E; PIZZA FX, "Muscle impairment occurs rapidly and precedes inflammatory cell accumulation after mechanical loading", Am J Physiol Regul Integr Comp Physiol., (20020000), vol. 282, pages R351 - 7-
DESCRIPTION- FRIEDRICH O; HUND E; WEBER C; HACKE W; FINK RH, "Critical illness myopathy serum fractions affect membrane excitability and intracellular Ca2+ release in mammalian skeletal muscle", J Neurol, (20040000), vol. 251, pages 53 - 65-
DESCRIPTION- FRIEDRICH O; HUND E; WEGNER F, "Enhanced muscle shortening and impaired Ca2+ channel function in an acute septic myopathy model", J Neurol., (20100000), vol. 257, pages 546 - 555, XP019802692-
DESCRIPTION- GLASS DJ, "Skeletal muscle hypertrophy and atrophy signaling pathways", Int J Biochem Cell Biol., (20050000), vol. 37, pages 1974 - 1984-
DESCRIPTION- GONYEA WJ; ERICSON GC, "An experimental model for the study of exercise-induced skeletal muscle hypertrophy", J Appl Physiol., (19760000), vol. 40, pages 630 - 633-
DESCRIPTION- GOONASEKERA SA; LAM CK; MILLAY DP; SARGENT MA; HAJJAR RJ; KRANIAS EG; MOLKENTIN JD, "Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle", J Clin Invest, (20110301), vol. 121, no. 3, pages 1044 - 52-
DESCRIPTION- HERNDON DN; RAMZY PI; DEBROY MA; ZHENG M; FERRANDO AA; CHINKES DL; BARRET JP; WOLFE RR; WOLF SE, "Muscle protein catabolism after severe burn: effects of IGF-l/IGFBP-3 treatment", Ann Surg., (19990000), vol. 229, pages 713 - 722-
DESCRIPTION- HOFBAUER LC; KHOSLA S; DUNSTAN CR; LACEY DL; BOYLE WJ; RIGGS BL, "The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption", J Bone Miner Res., (20000000), vol. 15, pages 2 - 12-
DESCRIPTION- HOLLINGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOOGENBOOM; WINTER, J. Mol. Biol., (19910000), vol. 227, page 381-
DESCRIPTION- HUND E, "Myopathy in critically ill patients", Crit Care Med., (19990000), vol. 27, pages 2544 - 2547-
DESCRIPTION- ILYIN EA; OGANOV VS, "Microgravity and musculoskeletal system of mammals", Adv Space Res., (19890000), vol. 9, pages 11 - 9-
DESCRIPTION- JONES et al., Nature, (19860000), vol. 321, pages 522 - 525-
DESCRIPTION- JOST PD, "Simulating human space physiology with bed rest", Hippokratia, (20080000), vol. 12, no. 1, pages 37 - 40-
DESCRIPTION- KOHLER et al., Nature, (19750000), vol. 256, page 495-
DESCRIPTION- KRAKAUER JC; MCKENNA MJ; RAO DS; WHITEHOUSE FW, "Bone mineral density in diabetes", Diabetes Care, (19970000), vol. 20, pages 1339 - 1340-
DESCRIPTION- KUBIS HP; HALLER EA; WETZEL P; GROS G, "Adult fast myosin pattern and Ca2+-induced slow myosin pattern in primary skeletal muscle culture", Proc Natl Acad Sci USA, (19970000), vol. 94, pages 4205 - 10-
DESCRIPTION- LACEY et al., Cell, (19980000), vol. 93, pages 165 - 176-
DESCRIPTION- LACOMIS D, "Critical illness myopathy", Curr Rheumatol Rep., (20020000), pages 403 - 408-
DESCRIPTION- LACOMIS D; PETRELLA JT; GIULIANI MJ, "Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients", Muscle Nerve, (19980000), vol. 21, pages 610 - 617-
DESCRIPTION- LANGEN RC; VAN DER VELDEN J.L; SCHOLS AM; KELDERS MC; WOUTERS EF; JANSSEN-HEININGER YM, "Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization", FASEB J., (20040000), vol. 18, pages 227 - 237-
DESCRIPTION- LARON Z; KLINGER B; SILBERGELD A, "Patients with Laron syndrome have Osteopenia/Osteoporosis", J Bone Miner Res., (19990000), vol. 14, pages 156 - 157-
DESCRIPTION- MARKS et al., J. Mol. Biol., (19910000), vol. 222, page 581-
DESCRIPTION- MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597-
DESCRIPTION- MARX SO; ONDRIAS K; MARKS AR, "Coupled gating between individual skeletal muscle Ca2+ release channels (ryanodine receptors", Science, (19980000), vol. 281, pages 818 - 821-
DESCRIPTION- MELZER W; HERRMANN-FRANK A; LUTTGAU HC, "The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres", Biochim Biophys Acta, (19950000), vol. 1241, pages 59 - 116-
DESCRIPTION- MOREY-HOLTON ER; GLOBUS RK, "Hindlimb unloading rodent model: technical aspects", J Appl Physiol., (20020000), vol. 92, pages 1367 - 77-
DESCRIPTION- MORINE KJ; SLEEPER MM; BARTON ER; SWEENEY HL, "Overexpression of SERCAla in the mdx diaphragm reduces susceptibility to contraction-induced damage", Hum Gene Ther., (20101200), vol. 21, no. 12, pages 1735 - 9-
DESCRIPTION- MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855-
DESCRIPTION- MOZAFFAR T; HADDAD F; ZENG M; ZHANG LY; ADAMS GR; BALDWIN KM, "Molecular and cellular defects of skeletal muscle in an animal model of acute quadriplegic myopathy", Muscle Nerve, (20070000), vol. 35, pages 55 - 65-
DESCRIPTION- MULLER, Meth. Enzym., (19830000), vol. 92, pages 589 - 601-
DESCRIPTION- NAYA FJ; MERCER B; SHELTON J; RICHARDSON JA; WILLIAMS RS; OLSON EN, "Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo", J Biol Chem., (20000000), vol. 275, pages 4545 - 4548-
DESCRIPTION- ODESSEY R; ALLEN ER; NEWMAN WP, "A model to study local effects of thermal trauma on muscle metabolism", Circ Shock., (19830000), vol. 11, pages 131 - 140-
DESCRIPTION- OGATA N; CHIKAZU D; KUBOTA N; TERAUCHI Y; TOBE K; AZUMA Y; OHTA T; KADOWAKI T; NAKAMURA K; KAWAGUCHI H, "Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover", J Clin Invest., (20000000), vol. 105, pages 935 - 943-
DESCRIPTION- Opinion in Pharmalogy, (20050000), vol. 5, pages 618 - 625-
DESCRIPTION- PAPADOPOULI AE; KLONARIS CN; THEOCHARIS SE, "Role of OPG/RANKL/RANK axis on the vasculature", Histol Histopathol, (20080000), vol. 23, pages 497 - 506-
DESCRIPTION- PASTORET C; SEBILLE A, "mdx mice show progressive weakness and muscle deterioration with age", J Neurol Sci., (19950000), vol. 129, pages 97 - 105-
DESCRIPTION- PENNER CG; GANG G; WRAY C; FISCHER JE; HASSELGREN PO, "The transcription factors NF-I b and AP-1 are differentially regulated in skeletal muscle during sepsis", Biochem Biophys Res Commun, (20010000), vol. 281, pages 1331 - 1336-
DESCRIPTION- PENNER G; GANG G; SUN X; WRAY C; HASSELGREN PO, "C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle", Am J Physiol Regul Integr Comp Physiol., (20020000), vol. 282, pages R439 - R444, XP002995235-
DESCRIPTION- PERRINI S; LAVIOLA L; CARREIRA MC; CIGNARELLI A; NATALICCHIO A; GIORGINO F, "The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis", J Endocrinol., (20100000), vol. 205, pages 201 - 210-
DESCRIPTION- PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, Springer-Verlag, (19940000), vol. 113, pages 269 - 315-
DESCRIPTION- PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596-
DESCRIPTION- QIN W; BAUMAN WA; CARDOZO C, "Bone and muscle loss after spinal cord injury: organ interactions", Ann N Y Acad Sci., (20100000), vol. 1211, pages 66 - 84-
DESCRIPTION- REICHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329-
DESCRIPTION- RIDINGS JE; PALMER AK; DAVIDSON EJ; BALDWIN JA., "Prenatal toxicity studies in rats and rabbits with the Ca2+ channel blocker diproteverine", Reprod Toxicol., (19960000), vol. 10, pages 43 - 49-
DESCRIPTION- RYDER JW; BASSEL-DUBY R; OLSON EN; ZIERATH JR, "Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways", J Biol Chem., (20030000), vol. 278, pages 44298 - 304.67-
DESCRIPTION- SANDRI M; SANDRI C; GILBERT A; SKURK C; CALABRIA E; PICARD A; WALSH K; SCHIAFFINO S; LECKER SH; GOLDBERG AL, "Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy", Cell, (20040000), vol. 117, pages 399 - 412, XP002338896-
DESCRIPTION- SCHAKMAN O; GILSON H; THISSEN JP, "Mechanisms of glucocorticoid-induced myopathy", J Endocrinol, (20080000), vol. 197, pages 1 - 10.75-
DESCRIPTION- SIMONET WS; LACEY DL; DUNSTAN CR; KELLEY M; CHANG MS; LUTHY R; NGUYEN HQ; WOODEN S; BENNETT L; BOONE T, "Osteoprotegerin: a novel secreted protein involved in the regulation of bone density", Cell, (19970000), vol. 89, pages 309 - 319-
DESCRIPTION- SMITH EL; GILLIGAN C, "Physical activity effects on bone metabolism", Calcif Tissue Int., (19910000), vol. 49, pages S50 - 54-
DESCRIPTION- SORIMACHI H; IMAJOH-OHMI S; EMORI Y; KAWASAKI H; OHNO S; MINAMI Y; SUZUKI K, "Molecular cloning of a novel mammalian Ca2+ -dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle", J Biol Chem., (19890000), vol. 264, pages 20106 - 11, XP002010549-
DESCRIPTION- SPENCER MJ; MELLGREN RL, "Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology", Hum Mol Genet, (20021001), vol. 11, no. 21, pages 2645 - 55-
DESCRIPTION- STRAUB V; RAFAEL JA; CHAMBERLAIN JS; CAMPBELL KP, "Animal models for muscular dystrophy show different patterns of sarcolemmal disruption", J Cell Biol., (19971020), vol. 139, no. 2, pages 375 - 85-
DESCRIPTION- SUGIURA T; MIYATA H; KAWAI Y; MATOBA H; MURAKAMI N, "Changes in myosin heavy chain isoform expression of overloaded rat skeletal muscles", Int J Biochem., (19930000), vol. 25, pages 1609 - 1613-
DESCRIPTION- TALMADGE RJ, "Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms", Muscle Nerve, (20000000), vol. 23, pages 661 - 679-
DESCRIPTION- TIAO G; LIEBERMAN M; FISCHER JE; HASSELGREN PO, "Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle", Am J Physiol., (19970000), vol. 272, pages R849 - R856-
DESCRIPTION- TISDALE MJ, "Cancer cachexia", Langenbecks Arch Surg., (20040000), vol. 389, pages 299 - 305-
DESCRIPTION- VAZQUEZ G; DE BOLAND AR; BOLAND RL, "1 alpha,25-dihydroxy-vitamin-D3-induced storeoperated Ca2+ influx in skeletal muscle cells. Modulation by phospholipase C, protein kinase C, and tyrosine kinases", J Biol Chem., (19980000), vol. 273, pages 33954 - 33960-
DESCRIPTION- VENTADOUR S; ATTAIX D, "Mechanisms of skeletal muscle atrophy", Curr Opin Rheumatol, (20060000), vol. 18, pages 631 - 635-
DESCRIPTION- WILLIAMS AB; DECOURTEN-MYERS GM; FISCHER JE; LUO G; SUN X; HASSELGREN PO, "Sepsis stimulates release of myofilaments in skeletal muscle by a Ca2+ -dependent mechanism", FASEB J., (19990000), vol. 13, pages 1435 - 1443-
DESCRIPTION- WONG et al., J. Exp. Med., (19970000), vol. 186, pages 2075 - 2080-
DESCRIPTION- WOOLF AD; PFLEGER B, "Burden of major musculoskeletal conditions", Bull World Health Organ., (20030000), vol. 81, pages 646 - 656-
DESCRIPTION- WOUTERS EF, "Muscle Wasting in Chronic Obstructive Pulmonary Disease", Am J Respir Crit Care Med., (20060000), vol. 173, pages 4 - 5-
DESCRIPTION- WROBLEWSKI R; NORDEMAR R, "Ultrastructural and histochemical studies of muscle in rheumatoid arthritis", Scand J Rheumatol., (19750000), pages 197 - 204-
DESCRIPTION- YANG H; MAMMEN J; WEI W; MENCONI M; EVENSON A; FAREED M; PETKOVA V; HASSELGREN PO, "Expression and activity of C/EBPO and delta are upregulated by dexamethasone in skeletal muscle", J Cell Physiol., (20050000), vol. 204, pages 219 - 226-
DESCRIPTION- YASUDA et al., Endocrinology, (19980000), vol. 139, page 1329-
DESCRIPTION- YASUDA et al., PNAS, (19980000), vol. 95, pages 3597 - 3602-
DESCRIPTION- YUN et al., J. Immunol., (19980000), vol. 161, pages 6113 - 6121-
DESCRIPTION- ZAPATA et al., Protein Eng., vol. 8, no. 10, pages 1057 - 1062-
DESCRIPTION- ZARZHEVSKY N; MENASHE O; CARMELI E; STEIN H; REZNICK AZ, "Capacity for recovery and possible mechanisms in immobilization atrophy of young and old animals", Ann N Y Acad Sci., (20010000), vol. 928, pages 212 - 225-
DESCRIPTION- BERGE et al., "Pharmaceutical Salts", J. of Phar. Sci., (19770100), vol. 66, no. 1, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560
DESCRIPTION- MIZUNO A; AMIZUKA N; IRIE K; MURAKAMI A; FUJISE N; KANNO T; SATO Y; NAKAGAWA N; YASUDA H; MOCHIZUKI S, "Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin", Biochem Biophys Res Commun, (19980000), vol. 247, doi:doi:10.1006/bbrc.1998.8697, pages 610 - 615, XP005300950
DESCRIPTION- LI H; MALHOTRA S; KUMAR A, "Nuclear factor-kappa B signaling in skeletal muscle atrophy", J Mol Med., (20080000), vol. 86, doi:doi:10.1007/s00109-008-0373-8, pages 1113 - 1126, XP019645225
DESCRIPTION- PANG MY; ENG JJ; MCKAY HA; DAWSON AS, "Reduced hip bone mineral density is related to physical fitness and leg lean mass in ambulatory individuals with chronic stroke", Osteoporos Int., (20050000), vol. 16, doi:doi:10.1007/s00198-005-1925-1, pages 1769 - 1779, XP019380850
DESCRIPTION- SIMONIDES WS; VAN HARDEVELD C, "An assay for sarcoplasmic reticulum Ca (+)-ATPase activity in muscle homogenates", Anal Biochem., (19900000), vol. 191, doi:doi:10.1016/0003-2697(90)90226-Y, pages 321 - 331, XP024830677
DESCRIPTION- GOLDSPINK DF, "The effects of denervation on protein turnover of the soleus and xtensor digitorum longus muscles of adult mice", Comp Biochem Physiol B., (19780000), vol. 61, doi:doi:10.1016/0305-0491(78)90210-9, pages 37 - 41, XP023528210
DESCRIPTION- MURTON AJ; CONSTANTIN D; GREENHAFF PL, "The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy", Biochim Biophys Acta, (20080000), vol. 1782, doi:doi:10.1016/j.bbadis.2008.10.011, pages 730 - 743, XP025691383
DESCRIPTION- MENCONI MJ; WEI W; YANG H; WRAY CJ; HASSELGREN PO, "Treatment of cultured myotubes with the Ca2+ ionophore A23187 increases proteasome activity via a CaMK II-caspasecalpain-dependent mechanism", Surgery, (20040000), vol. 136, doi:doi:10.1016/j.surg.2004.03.014, pages 135 - 142, XP004541846
DESCRIPTION- ROCK KL; GRAMM C; ROTHSTEIN L; CLARK K; STEIN R; DICK L; HWANG D; GOLDBERG AL, "Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules", Cell, (19940000), vol. 78, doi:doi:10.1016/S0092-8674(94)90462-6, pages 761 - 771, XP024246453
DESCRIPTION- LUNN MR; WANG CH, "Spinal muscular atrophy", Lancet, (20080000), vol. 371, doi:doi:10.1016/S0140-6736(08)60921-6, pages 2120 - 2133, XP022758609
DESCRIPTION- MUSARO A; MCCULLAGH K; PAUL A; HOUGHTON L; DOBROWOLNY G; MOLINARO M; BARTON ER; SWEENEY HL; ROSENTHAL N, "Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle", Nat Genet, (20010000), vol. 27, doi:doi:10.1038/84839, pages 195 - 200, XP001199471
DESCRIPTION- MUSARO A; GIACINTI C; BORSELLINO G; DOBROWOLNY G; PELOSI L; CAIRNS L; OTTOLENGHI S; COSSU G; BERNARDI G; BATTISTINI L, "Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1", Proc Natl Acad Sci U S A, (20040000), vol. 101, doi:doi:10.1073/pnas.0303792101, pages 1206 - 1210, XP002388524
DESCRIPTION- REIKEN S; LACAMPAGNE A; ZHOU H; KHERANI A; LEHNART SE; WARD C; HUANG F; GABURJAKOVA M; GABURJAKOVA J; ROSEMBLIT N, "PKA phosphorylation activates the Ca2+ release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure", J Cell Biol., (20030000), vol. 160, doi:doi:10.1083/JCB.200211012, pages 919 - 928, XP002531402
DESCRIPTION- DOUGALL WC; GLACCUM M; CHARRIER K; ROHRBACH K; BRASEL K; DE SMEDT T; DARO E; SMITH J; TOMETSKO ME; MALISZEWSKI CR, "RANK is essential for osteoclast and lymph node development", Genes Dev., (19990000), vol. 13, doi:doi:10.1101/gad.13.18.2412, pages 2412 - 2424, XP002228678
DESCRIPTION- BODINE SC; LATRES E; BAUMHUETER S; LAI VK; NUNEZ L; CLARKE BA; POUEYMIROU WT; PANARO FJ; NA E; DHARMARAJAN K, "Identification of ubiquitin ligases required for skeletal muscle atrophy", Science, (20010000), vol. 294, doi:doi:10.1126/science.1065874, pages 1704 - 1708, XP002386330
DESCRIPTION- CATTERALL WA, "Structure and regulation of voltage-gated Ca2+ channels", Annu Rev Cell Dev Biol., (20000000), vol. 16, doi:doi:10.1146/annurev.cellbio.16.1.521, pages 521 - 555, XP002313942
INTERNATIONAL-SEARCH-REPORT- GALLAGHER, J. C. ET AL., "Advances in Bone Biology and New Treatments for Bone Loss", MATURITAS, (20080613), vol. 60, pages 65 - 69, XP022776930
INTERNATIONAL-SEARCH-REPORT- RESCH, H., "Osteoporosis: New-Generation Drugs", BREAST CARE, (20101026), vol. 5, pages 313 - 319, XP055067039
OPPOSITION- CROCKETT et al., "Signal peptide mutations in RANK prevent downstream activation of NF-κB", Journal of Bone and Mineral Research, (20110000), vol. 26, no. 8, pages 1926 - 1938, XP055617028-
OPPOSITION- DEBIGARE et al., "Peripheral Muscle Wasting in Chronic Obstructive Pulmonary Disease", Am. J. Respir Crit Care Med., (20010000), vol. 164, pages 1712 - 1717, XP055617037-
OPPOSITION- Stina SALOMONSSON et al., "Cytokines in idiopathic inflammatory myopathies", Autoimmunity, (20060500), vol. 39, no. 3, pages 177 - 190, XP055616979-
OPPOSITION- TOMOMURA et al., "Serum Calcium-decreasing Factor, Caldecrin, Ameliorates Muscular Dystrophy in dy/dy Mice", in vivo, (20110000), vol. 25, pages 157 - 163, XP055616982-
OPPOSITION- WÜST et al., "Factors contributing to muscle wasting and dysfunction in COPD patients", International Journal of COPD, (20070000), vol. 2, no. 3, pages 289 - 300, XP055617034-
OPPOSITION- LEFKOWITZ et al., "Treatment of facioscapulohumeral muscular dystrophy with Denosumab", American Journal of Case Reports,, (20120516), vol. 13, pages 66 - 68, XP055174754
SEARCH- PAUL D MILLER, "Denosumab: Anti-RANKL antibody", CURRENT OSTEOPOROSIS REPORTS, (20090301), vol. 7, no. 7, pages 18 - 22, XP055038533 [Y] 6 * the whole document *
SEARCH[XPYI] - STANLEY S. LEFKOWITZ ET AL, "Treatment of facioscapulohumeral muscular dystrophy with Denosumab", AMERICAN JOURNAL OF CASE REPORTS, (20120516), vol. 13, doi:10.12659/AJCR.882771, ISSN 1941-5923, pages 66 - 68, XP055174754 [XP] 1-7,9 * the whole document * [Y] 11-13 [I] 4,8,10

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents